Notice Health and Human Services DepartmentFood and Drug Administration April 16, 2026

Notice of Approval of Product Under Priority Review Voucher; Material Threat Medical Countermeasure Priority Review Voucher; MRESVIA (Respiratory Syncytial Virus Vaccine)

The Food and Drug Administration (FDA) is announcing the approval of a product redeeming a material threat medical countermeasure (MCM) priority review voucher. The Federal Food, Drug, and Cosmetic...

Sign up to read the full analysis
Document type: Notice. Agency: Health and Human Services Department, Food and Drug Administration. Published: 2026-04-16.

Why this matters to food and beverage teams

This notice is worth screening if your team tracks health and human services department, food and drug administration activity that could affect ingredients, labeling, plant operations, imports, or compliance timing.

Federal Register items are often early signals. Even when they look procedural, they can affect comment windows, effective dates, or how suppliers and plants plan around upcoming changes.

View original source document

Track this document and its deadlines

Get the full analysis, comment period alerts, and compliance calendar -- free for F&B professionals.

Sign Up Free